Company Profile · Communication Services

John Wiley & Sons

WLY · US
Country
USA
IPO date
Apr 1, 2022
Employees
4,500
Buffett Score
41/100
Weak
Market cap$2.48B
Revenue (TTM)$1.67B
EBITDA$349.38M
Profit margin11.9%
ROE25.91%
P/E (TTM)12.87
Forward P/E15.27
PEG13.05
EPS$3.80
Dividend yield2.98%
52-week range$27.93 – $57.45
Analyst target$68.00
Analyst rating4.0 / 5

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

John Wiley & Sons, Inc., a publisher, provides authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning in the United States, the United Kingdom, Germany, and internationally. It operates through Research and Learning segment. The company's Research segment provides scientific, technical, medical, and scholarly journals, as well as related content and services in the areas of physical sciences and engineering, health sciences, social sciences, and humanities, and life sciences. This segment sells its products direct to research libraries and library consortia, as well as to researchers and professional society members, and other customers; and through independent subscription agents. The company's Learning segment offers scientific, professional, and education print and digital books; digital courseware to support students and instructors, and assessment services for businesses and professionals. This segment sells its products and services to business and leadership, technology, behavioral health, engineering/architecture, science, and professional education categories through brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, distributor networks, and government agencies. John Wiley & Sons, Inc. was founded in 1807 and is headquartered in Hoboken, New Jersey.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.